United StatesStem Cell Therapeutic and Research Reauthorization Act of 2025
What it does
This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).
More detail
The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research.
Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jul 21Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.Latest
- Jul 20Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- Jul 20Considered under suspension of the rules. (consideration: CR H4642-4643)
- Jul 20DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
- Jul 20Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)Passed House
- Jul 20Motion to reconsider laid on the table Agreed to without objection.
- Jul 2Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
- Jul 2Placed on the Union Calendar, Calendar No. 629.
- May 21Committee Consideration and Mark-up Session Held
- May 21Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- May 13Subcommittee Consideration and Mark-up Session Held
- May 13Forwarded by Subcommittee to Full Committee by Voice Vote.
- 2025
- Sep 4Introduced in House
- Sep 4Referred to the House Committee on Energy and Commerce.
- Sep 4Referred to the Subcommittee on Health.Introduced